Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Moderately Early (7-14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/repview. Accessed 02 May 2024.
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/repview. Accessed May 2, 2024.
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/repview
Moderately Early (7-14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants: Cochrane systematic review
ID - 433721
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433721/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -